Showing 171-180 of 4131 results for "".
The Excoriated and Bleeding Edge: Updates in Eczema for the Clinician
https://practicaldermatology.com/topics/general-topics/the-excoriated-and-bleeding-edge-updates-in-eczema-for-the-clinician/21469/Atopic dermatitis continues to present treatment challenges, but a steady juggling of four main components—moisturization, antibiotics, anti-inflammatory, and antipruritics— help to maximize control of the disease.Finding the Perfect Sunscreen for Patients with Skin of Color
https://practicaldermatology.com/columns/skin-cancer-essentials/finding-the-perfect-sunscreen-for-patients-with-skin-of-color/56391/There are a few existing resources that have reviewed and rated sunscreen products and their components;5 few are in scientific journals, and many are short magazine review articles with only a few selections discussed. A team of experts provides comprehensive resource on sunscreens compatible withLose Your Inhibitions: Expanding Use of JAK Inhibitors
https://practicaldermatology.com/topics/atopic-dermatitis/lose-your-inhibitions-expanding-use-of-jak-inhibitors/23910/Despite data on safety concerns, dermatologists and patients see benefits.Jejunal Trichobezoar in a 3-year-old Boy; Practice Path MD Pro Tip: Architects
https://practicaldermatology.com/youngmd-connect/resident-resource-center/jejunal-trichobezoar-in-a-3-year-old-boy-practice-path-md-pro-tip-architects/20697/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-45/23890/Fresh Perspectives on Systemic Treatment of Dermatologic Diseases
https://practicaldermatology.com/topics/practice-management/fresh-perspectives-on-systemic-treatment-of-dermatologic-diseases/21056/From urticaria to atopic dermatitis, there are new approaches to treatment and better understanding of pathogenesis.Annual Trends in Medicare Part D Prescription Claims for Guselkumab, 2018–2020
https://practicaldermatology.com/programs/practical-dermatology-focus-psoriasis/annual-trends-in-medicare-part-d-prescription-claims-for-guselkumab-20182020/28861/Jachin Wu, MD, FAAD, and colleagues talk about Medicare claims for guselkumabCutaneous Manifestations Associated with Nemolizumab
https://practicaldermatology.com/issues/september-2025/cutaneous-manifestations-associated-with-nemolizumab/37628/In the 2025 study by Sasaki et al entitled “Clinical characteristics and risk factors for cutaneous manifestations associated with nemolizumab in atopic dermatitis: a multicenter retrospective study in Japan,” nemolizumab-induced cutaneous eruptions were found to be relatively common, typically occuPhysician Spotlight: Mathew Avram, MD, JD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-mathew-avram-md-jd/23633/DermWireTV 09.12.19: Otezla to Amgen, A Juvéderm First, Skin Cancer Foundation News
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-091219-otezla-to-amgen-a-juvederm-first-skin-cancer-foundation-news/19663/After traveling more than 10,000 miles across the US, the Skin Cancer Foundation’s “Destination: Healthy Skin” Program is wrapping up for the season. Plus, the Champions for Change Gala is coming October 17. Amgen has entered into an agreement with Celgene Corporation Company to acquire worldwide ri